Page last updated: 2024-11-11

desmethylicaritin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

desmethylicaritin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5318624
CHEMBL ID192159
SCHEMBL ID4223551
MeSH IDM0483271

Synonyms (30)

Synonym
desmethylicaritin
CHEMBL192159
FT-0666133
noranhydroicaritin
LMPK12111981
8-prenylkaempferol
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one
de-o-methylanhydroicaritin
28610-31-3
desmethyl icaritin
4'-desmethylicaritin
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-4h-1-benzopyran-4-one
3,4',5,7-tetrahydroxy-8-(3-methyl-2-butenyl)flavone
SCHEMBL4223551
W-202198
AKOS025288161
DTXSID70415743
noranhydroicartin
unii-0v5xk67y0s
8-c-prenylkaempferol
4h-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-
0V5XK67Y0S ,
J94.449A ,
4'-desmethylicaritin; 8-c-prenylkaempferol; 8-prenylkaempferol; de-o-methylanhydroicaritin; desmethylanhydroicaritin; desmethylicaritin
Q27237292
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-4h-chromen-4-one
A937200
B0005-260423
8-prenylkaempferol (desmethyl icaritin)
FS-7687

Research Excerpts

Overview

Desmethylicaritin is a bioactive metabolite of Epimedium flavonoids in serum.

ExcerptReferenceRelevance
"Desmethylicaritin is a bioactive metabolite of Epimedium flavonoids in serum."( Phytoestrogenic molecule desmethylicaritin suppressed adipogenesis via Wnt/β-catenin signaling pathway.
Dai, Y; Liu, MY; Qin, L; Wang, N; Wang, XL; Xie, XH; Yao, D; Yao, XS; Yao, ZH; Zhang, G; Zheng, LZ, 2013
)
1.41

Compound-Compound Interactions

ExcerptReferenceRelevance
" A high-performance liquid chromatography with a diode array detector combined with electrospray ionization ion trap time-of-flight multistage mass spectrometry (HPLC-DAD-ESI-IT-TOF-MS(n) ) method was established to profile and identify the metabolites of 8-prenylkaempferol in rat in vivo and in vitro, and to study the distribution of these metabolites in rats for the first time."( The profiling and identification of the metabolites of 8-prenylkaempferol and a study on their distribution in rats by high-performance liquid chromatography with diode array detection combined with electrospray ionization ion trap time-of-flight multista
Cai, SQ; Li, FC; Liu, GX; Ma, LM; Shang, MY; Wang, JZ; Xu, F, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
" In order to examine their bioavailability in humans, we have developed and validated a sensitive method to quantify icaritin and desmethylicaritin in human sera, using gas chromatography-mass spectrometry."( Sensitive and rapid method to quantify icaritin and desmethylicaritin in human serum using gas chromatography-mass spectrometry.
Shen, P; Wong, SP; Yong, EL, 2007
)
0.8
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID250527Antiproliferative effect against human colonic cell line (HT-29) after 6 hr at a concentration of 50 uM2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study.
AID250567Antiproliferative effect against human colonic cell line (HT-29) after 24 hr at a concentration of 50 uM2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study.
AID252875Caspase 3/7 activity is expressed as ratio of caspase activation in treated human colonic cell line (HT-29) to that of untreated control cells after 5 hr2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (57.14)29.6817
2010's5 (35.71)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.77 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]